Most cited papers from Aflac (United States)

Aflac (United States)

What are the most cited papers from Aflac (United States)?

The most cited paper from Aflac (United States) is "Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program" (Daniel Taliun et al., 2021), with 2,381 citations. Next come "Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort" (1,177) and "Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009" (786).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 98 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program Daniel Taliun et al. · Nature Open access427 authors	10 Feb 2021	2,381
2	Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort Daniel A. Mulrooney, Mark W. Yeazel, Toana I. Kawashima et al. · BMJ Open access	8 Dec 2009	1,177
3	Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009 Sung‐Yun Pai et al. · New England Journal of Medicine Open access	30 Jul 2014	786
4	Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia Elena J. Orlando et al. · Nature Medicine	27 Sep 2018	589
5	ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease Paula James, Nathan T. Connell, Barbara Ameer et al. · Blood Advances Open access	12 Jan 2021	582
6	Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow Jessica L. Halliley et al. · Immunity Open access	Jul 2015	569
7	Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation Éliane Gluckman et al. · Blood Open access	13 Dec 2016	493
8	International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease Frits van Rhee et al. · Blood Open access	4 Sep 2018	427
9	Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial Theodore Willis Laetsch et al. · Journal of Clinical Oncology Open access	18 Nov 2022	382
10	Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review Ilenia Mastrolia, Elisabetta Manuela Foppiani, Alba Murgia et al. · Stem Cells Translational Medicine Open access	16 Jul 2019	367
11	Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium Dolores H Lopez-Terrada, Rita Alaggio, Maria del Carmen Calle Dávila et al. · Modern Pathology Open access	6 Sep 2013	355
12	Nyströmformer: A Nyström-based Algorithm for Approximating Self-Attention Yunyang Xiong, Zhanpeng Zeng, Rudrasis Chakraborty et al. · Proceedings of the AAAI Conference on Artificial Intelligence Conference paperOpen access	18 May 2021	340
13	T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene et al. · Nature Medicine Open access	13 Jan 2022	337
14	Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia Barthelemy Diouf et al. · JAMA Open access	24 Feb 2015	285
15	Extracellular hemin crisis triggers acute chest syndrome in sickle mice Samit Ghosh, Olufolake Adetoro Adisa, Prasanthi Chappa et al. · Journal of Clinical Investigation Open access	30 Sep 2013	279
16	Cancer Incidence Rates and Trends Among Children and Adolescents in the United States, 2001–2009 David A. Siegel, Jessica Blythe King, Eric W. Tai et al. · PEDIATRICS Open access	9 Sep 2014	276
17	Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD Benjamin K. Watkins et al. · Journal of Clinical Oncology Open access	15 Jan 2021	262
18	Mechanisms of platelet clearance and translation to improve platelet storage M. Edward Quach, Wenchun Chen, Renhao Li · Blood Open access	23 Feb 2018	232
19	International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease Frits van Rhee et al. · Blood Advances Open access	7 Dec 2020	222
20	Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group Renée L. Mulder et al. · The Lancet Oncology Open access	Feb 2021	211
21	SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery Élie Haddad et al. · Blood Open access	28 Aug 2018	178
22	Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma Sharon M. Castellino, Qinglin Pei, Susan Kenyon Parsons et al. · New England Journal of Medicine Open access	2 Nov 2022	171
23	Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL Qiang Jeremy Wen et al. · Cell Open access	Aug 2012	157
24	Management of pediatric low-grade glioma Peter M K de Blank, Pratiti Bandopadhayay, Daphne Adele Haas-Kogan et al. · Current Opinion in Pediatrics Open access	7 Dec 2018	150
25	Toward optimal therapy for inhibitors in hemophilia Christine L. Kempton, Shannon L. Meeks · Blood Open access	27 Nov 2014	148
26	National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report Daniel Wolff et al. · Transplantation and Cellular Therapy Open access	10 Jun 2021	146
27	Platelet Transfusion Practices Among Neonatologists in the United States and Canada: Results of a Survey Cassandra D. Josephson, Leon Su, Robert D. Christensen et al. · PEDIATRICS	29 Dec 2008	146
28	Live-cell super-resolved PAINT imaging of piconewton cellular traction forces Joshua M. Brockman, Hanquan Su, Aaron T. Blanchard et al. · Nature Methods Open access	14 Sep 2020	145
29	Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results Kelly C. Goldsmith et al. · Nature Medicine Open access	3 Apr 2023	143
30	Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report Lauri M. Burroughs et al. · Blood Open access	8 Apr 2020	143
31	The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma Minghui Li, Aaron R. Bolduc, Md Nasrul Hoda et al. · Journal for ImmunoTherapy of Cancer Open access	2014	143
32	Actin Cytoskeletal Disruption following Cryopreservation Alters the Biodistribution of Human Mesenchymal Stromal Cells In Vivo Raghavan Chinnadurai, Marco Garcia, Yumiko Sakurai et al. · Stem Cell Reports Open access	6 Jun 2014	143
33	Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies Melissa M. Hudson, Joseph P. Neglia, William G. Woods et al. · Pediatric Blood & Cancer Open access	28 Oct 2011	140
34	Chronic Kidney Disease and Albuminuria in Children with Sickle Cell Disease Marianne McPherson Yee, Shameem Jabbar, Ifeyinwa Osunkwo et al. · Clinical Journal of the American Society of Nephrology Open access	22 Sep 2011	138
35	Therapeutic options for CTLA-4 insufficiency David Egg et al. · Journal of Allergy and Clinical Immunology Open access	7 Jun 2021	137
36	Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival Bree Ruppert Eaton, Natia Esiashvili, Sungjin Kim et al. · International Journal of Radiation OncologyBiologyPhysics Open access	18 Sep 2015	134
37	Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome Jennifer W. Leiding et al. · Journal of Allergy and Clinical Immunology Open access225 authors	11 Oct 2022	132
38	Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series Robert Sheppard Nickel, Jeanne E. Hendrickson, Ross M. Fasano et al. · Transfusion	28 Oct 2015	132
39	ABO-mismatched platelet transfusions: Strategies to mitigate patient exposure to naturally occurring hemolytic antibodies Cassandra D. Josephson, Marta‐Inés Castillejo, Kathleen M. Grima et al. · Transfusion and Apheresis Science	20 Jan 2010	131
40	Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium Monica S. Thakar et al. · The Lancet Open access	20 Jun 2023	130
41	Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted EPOCH ‐R Lisa G. Giulino-Roth et al. · British Journal of Haematology Open access	29 Oct 2017	130
42	Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease Mark C. Walters, Laura M. De Castro, Keith M. Sullivan et al. · Transplantation and Cellular Therapy Open access	24 Oct 2015	127
43	CEBPA -bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group Katherine Tarlock, Adam J. Lamble, Yi‐Cheng Wang et al. · Blood Open access	6 May 2021	125
44	IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression Chenhui Wang, Cun-Jin Zhang, Bradley N. Martin et al. · Nature Communications Open access	31 May 2017	125
45	Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the M alignant G erm C ell T umor I nternational C ollaborative Farzana Pashankar, Juliet Hale, Ha Dang et al. · Cancer Open access	20 Oct 2015	120
46	Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling Stefan Alig et al. · Nature Open access	11 Dec 2023	115
47	Obesity-induced dysregulation of skin-resident PPARγ+ Treg cells promotes IL-17A-mediated psoriatic inflammation Pulavendran Sivasami, Cody M. Elkins, Pamela P. Diaz-Saldana et al. · Immunity Open access	20 Jul 2023	115
48	ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma Isabel Arrillaga‐Romany et al. · Journal of Clinical Oncology Open access	9 Feb 2024	112
49	MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system Justus M. Huelse, Diana M. Fridlyand, Shelton H. Earp et al. · Pharmacology & Therapeutics Open access	14 May 2020	112
50	Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations Charline Miot et al. · Blood Open access	5 Jul 2017	112

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.